Fact CheckerSign in

NCT04649034Completed

Intraventricular Stasis In Cardiovascular Disease

Personalizing The Risk Of Stroke And Silent Brain Infarct In Cardiovascular Disease

Source: ClinicalTrials.gov · Last updated 15 Sept 2025

Brief summary (registry, in English)

This study is designed to quantify the ventricular stasis in patients with different forms of cardiomyopathy and at risk of stroke (ischemic, non-ischemic dilated cardiomyopathy and hypertrophic cardiomyopathy) by post-processing of 2D color Doppler echocardiography and phase contrast-magnetic resonance images in order to establish the relationship between quantitative variables of intraventricular stasis and the prevalence of silent embolic events and/or intraventricular mural thrombosis.

Status (registry)
Completed
Study type
Observational
Enrollment
258 (actual)
First submitted
24 Nov 2020
Start date
24 Nov 2020
Primary completion date
31 Dec 2024
Lead sponsor
Hospital General Universitario Gregorio Marañon
NCT number
NCT04649034

What you commit to

  • Study type: Observational
  • Participants enrolled: 258
  • From 24 Nov 2020 to the primary completion date, 31 Dec 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of significant carotid disease with stenosis greater than 50%.
  • Full anticoagulation therapy prior to admission or indication of anticoagulation.

Other illness

  • Hemodinamically significant heart valve disease or prosthetic heart valves.
  • Pro-thrombotic disorders (active oncology disease, coagulation disorders…)

Other

  • Implantable defibrillation or stimulation devices not compatible with MRI.
  • Claustrophobia.
  • Persistent of paroxysmal atrial fibrillation (AF).

Who the study is looking for

  • Patients over 18 years of age.
  • Sinus rhythm.
  • Meet one of the following criteria:
    • Diagnosis of non ischemic DCM and ejection fraction (EF) of LV less than 45%
    • Diagnosis of ischemic DCM and ejection fraction (EF) of LV less than 45%
    • Diagnosis of hypertrofic myocardiophathy and ejection fraction (EF) of LV less than 55% or apical aneurism diagnosed in an image test.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Clinic de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Universitario Clinico de Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.